Oppenheimer on Bicycle Therapeutics (BCYC): 'Near-Term Update Should Sharpen Focus'
Tweet Send to a Friend
Oppenheimer analyst Jay Olson reiterated an Outperform rating and $44.00 price target on Bicycle Therapeutics (NASDAQ: BCYC).The analyst comments "BCYC ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
